A trade deal has been struck with 11 countries on both sides of the Pacific, including Canada.
For smaller countries, access to the U.S. market is a major prize.
Canadas lagging intellectual property (IP) protections for pharmaceutical innovators are a key issue to be settled in the Comprehensive Economic and Trade Agreement (CETA) negotiations with the European Union. They may also play a role in upcoming negotiations for the multi-country Trans-Pacific Partnership (TPP).
Trade and Economic Benefits of Enhanced Intellectual Property Protection for Pharmaceuticals in Canada
There are few Canadians who understand agricultural supply management and how it affects their daily lives, which is a major reason why this outdated system has survived. Its receiving greater scrutiny now, though, because its impeding trade agreements.